Smith & Nephew plc

FTSE 100 shares end higher

London shares closed higher on Tuesday as investors reacted to positive corporate figures.
 

London shares edge higher

London shares edged higher by the close on Monday amid hopes that a political deal is in the works over the looming US fiscal cliff.
 

London shares fall

London shares fell at the end of trade on Thursday after the European Central Bank disappointed investors who had been hoping it would announce immediate new measures to resolve the eurozone debt crisis.
 

London shares plunge as Draghi says no action yet

London shares plunged in afternoon trade, losing their earlier gold medal bounce, after European Central Bank president Mario Draghi announced no immediate new monetary measures to ease debt pressures in the eurozone.
 

London shares get gold medal bounce

London shares got a gold medal bounce on Thursday, opening higher in the wake of Britain's first victories of the Olympics and some strong corporate results.
 

London shares rise on hope of EU, US stimulus

London shares opened higher on Monday amid hopes for new rounds of central bank stimulus in Europe and the United States to kickstart their troubled economies.
 

London stocks slide on Greece exit warning

London stocks plunged lower on Wednesday ahead of an informal EU summit and after the former Greek prime minister warned that Greece might leave the eurozone.
 

Special Report: A prescription for corruption

BELGRADE (Reuters) - According to a signal from the electronic tag around his ankle, Nenad Borojevic last left his apartment building at 6.25 p.m. on January 10. It was the festive season in Serbia; the capital was enjoying the lull between Orthodox Christmas and New Year.
 

Britain wants life-long checks on metal hip implants

LONDON (Reuters) - Most British patients with all-metal artificial hips should be followed up for life with annual tests to check for problems, Britain's medical regulator said on Tuesday.
 

UK calls for life-long checks on metal hip implants

LONDON (Reuters) - Most British patients with all-metal artificial hips should be followed up for the life of the implant with annual tests to monitor for problems, including exposure to toxic metals, Britain's medical regulator said on Tuesday.
 

Beware knee-jerk reform after PIP case: UK regulator

LONDON (Reuters) - There is no need for radical reform of Europe's medical device regulation system in the wake of a scandal over French PIP breast implants, Britain's medical regulator said on Thursday, but some improvements should be made to the current system.
 

Metal hip lubricant reduces wear and tear: study

CHICAGO (Reuters) - A substance that forms in patients with all-metal artificial hips turns out to contain the common lubricant graphite, a discovery that could help in designing longer lasting implants, researchers said.
 

US baby boomers feed need for joint replacements

US baby boomers are fueling a wave of joint replacement surgeries, hoping to use new artificial knees and hips to stay active as they get older.
 

New report highlights metal hip implant problems

(Reuters) - Modern, all-metal hip implants appear no more effective than traditional implants and may be less safe, according to a new report, a finding that could hurt the device makers and accelerate lawsuits.
 

New report highlights metal hip implant problems

(Reuters) - Modern, all-metal hip implants appear no more effective than traditional implants and may be less safe, according to a new report, a finding that could hurt orthopedic companies that make the devices and accelerate lawsuits.
 

London shares open higher as miners recover

London shares opened higher on Tuesday as mining and resources stocks bounced back from recent losses.
 

London shares close flat

Shares in London ended virtually unchanged after choppy trade Tuesday, with investors keeping a wary eye on the eurozone debt crisis as Italian, Spanish and French borrowing costs spiked worryingly higher.
 

S&N profit falls on high orthopedics costs

LONDON (Reuters) - Smith & Nephew, Europe's largest artificial hip and knee maker, posted 9 percent lower third-quarter trading profit, saying its costs were too high for the subdued orthopedics market.
 

Million-dollar payments to surgeons raise questions

NEW YORK (Reuters Health) - Orthopedic surgeons have received hundreds of millions of dollars from joint implant manufacturers in recent years, according to a report released Monday.
 

Derma sees partner for new drug in first half 2012

NEW YORK (Reuters) - Derma Sciences Inc expects to find a deep-pocketed partner for its treatment for diabetes-induced foot ulcers in the first half of 2012, even before it enrolls patients for late-stage trials.